821 related articles for article (PubMed ID: 8686508)
1. In vitro and ex vivo evidence that estrogens suppress increased bone resorption induced by ovariectomy or PTH stimulation through an effect on osteoclastogenesis.
Most W; Schot L; Ederveen A; van der Wee-Pals L; Papapoulos S; Löwik C
J Bone Miner Res; 1995 Oct; 10(10):1523-30. PubMed ID: 8686508
[TBL] [Abstract][Full Text] [Related]
2. A novel synthetic triazolotriazepine derivative JTT-606 inhibits bone resorption by down-regulation of action and production of bone resorptive factors.
Chikazu D; Shindo M; Iwasaka T; Katagiri M; Manabe N; Takato T; Nakamura K; Kawaguchi H
J Bone Miner Res; 2000 Apr; 15(4):674-82. PubMed ID: 10780859
[TBL] [Abstract][Full Text] [Related]
3. Lack of evidence for an increase in interleukin-6 expression in adult murine bone, bone marrow, and marrow stromal cell cultures after ovariectomy.
Vargas SJ; Naprta A; Lee SK; Kalinowski J; Kawaguchi H; Pilbeam CC; Raisz LG; Lorenzo JA
J Bone Miner Res; 1996 Dec; 11(12):1926-34. PubMed ID: 8970895
[TBL] [Abstract][Full Text] [Related]
4. Everolimus suppresses cancellous bone loss, bone resorption, and cathepsin K expression by osteoclasts.
Kneissel M; Luong-Nguyen NH; Baptist M; Cortesi R; Zumstein-Mecker S; Kossida S; O'Reilly T; Lane H; Susa M
Bone; 2004 Nov; 35(5):1144-56. PubMed ID: 15542040
[TBL] [Abstract][Full Text] [Related]
5. Cytokine-induced nitric oxide inhibits bone resorption by inducing apoptosis of osteoclast progenitors and suppressing osteoclast activity.
van't Hof RJ; Ralston SH
J Bone Miner Res; 1997 Nov; 12(11):1797-804. PubMed ID: 9383684
[TBL] [Abstract][Full Text] [Related]
6. Thyroid-stimulating hormone restores bone volume, microarchitecture, and strength in aged ovariectomized rats.
Sampath TK; Simic P; Sendak R; Draca N; Bowe AE; O'Brien S; Schiavi SC; McPherson JM; Vukicevic S
J Bone Miner Res; 2007 Jun; 22(6):849-59. PubMed ID: 17352644
[TBL] [Abstract][Full Text] [Related]
7. Leukemia inhibitory factor inhibits osteoclastic resorption, growth, mineralization, and alkaline phosphatase activity in fetal mouse metacarpal bones in culture.
Van Beek E; Van der Wee-Pals L; van de Ruit M; Nijweide P; Papapoulos S; Löwik C
J Bone Miner Res; 1993 Feb; 8(2):191-8. PubMed ID: 8442437
[TBL] [Abstract][Full Text] [Related]
8. Interleukin-7 influences osteoclast function in vivo but is not a critical factor in ovariectomy-induced bone loss.
Lee SK; Kalinowski JF; Jacquin C; Adams DJ; Gronowicz G; Lorenzo JA
J Bone Miner Res; 2006 May; 21(5):695-702. PubMed ID: 16734384
[TBL] [Abstract][Full Text] [Related]
9. Heat shock protein 60 causes osteoclastic bone resorption via toll-like receptor-2 in estrogen deficiency.
Koh JM; Lee YS; Kim YS; Park SH; Lee SH; Kim HH; Lee MS; Lee KU; Kim GS
Bone; 2009 Oct; 45(4):650-60. PubMed ID: 19527807
[TBL] [Abstract][Full Text] [Related]
10. Vitamin D hormone inhibits osteoclastogenesis in vivo by decreasing the pool of osteoclast precursors in bone marrow.
Shibata T; Shira-Ishi A; Sato T; Masaki T; Masuda A; Hishiya A; Ishikura N; Higashi S; Uchida Y; Saito MO; Ito M; Ogata E; Watanabe K; Ikeda K
J Bone Miner Res; 2002 Apr; 17(4):622-9. PubMed ID: 11918219
[TBL] [Abstract][Full Text] [Related]
11. Endogenous bone-resorbing factors in estrogen deficiency: cooperative effects of IL-1 and IL-6.
Miyaura C; Kusano K; Masuzawa T; Chaki O; Onoe Y; Aoyagi M; Sasaki T; Tamura T; Koishihara Y; Ohsugi Y
J Bone Miner Res; 1995 Sep; 10(9):1365-73. PubMed ID: 7502709
[TBL] [Abstract][Full Text] [Related]
12. Quinoxaline derivative of oleanolic acid inhibits osteoclastic bone resorption and prevents ovariectomy-induced bone loss.
Zhao Y; Huai Y; Jin J; Geng M; Li JX
Menopause; 2011 Jun; 18(6):690-7. PubMed ID: 21228726
[TBL] [Abstract][Full Text] [Related]
13. Effect of high phosphate concentration on osteoclast differentiation as well as bone-resorbing activity.
Kanatani M; Sugimoto T; Kano J; Kanzawa M; Chihara K
J Cell Physiol; 2003 Jul; 196(1):180-9. PubMed ID: 12767054
[TBL] [Abstract][Full Text] [Related]
14. An assay system utilizing devitalized bone for assessment of differentiation of osteoclast progenitors.
Amano S; Hanazawa S; Kawata Y; Ohta K; Kitami H; Kitano S
J Bone Miner Res; 1992 Mar; 7(3):321-8. PubMed ID: 1585834
[TBL] [Abstract][Full Text] [Related]
15. Inducible production of nitric oxide in osteoblast-like cells and in fetal mouse bone explants is associated with suppression of osteoclastic bone resorption.
Löwik CW; Nibbering PH; van de Ruit M; Papapoulos SE
J Clin Invest; 1994 Apr; 93(4):1465-72. PubMed ID: 8163651
[TBL] [Abstract][Full Text] [Related]
16. Estradiol and raloxifene decrease the formation of multinucleate cells in human bone marrow cultures.
Ramalho AC; Couttet P; Baudoin C; Morieux C; Graulet AM; de Vernejoul MC; Cohen-Solal ME
Eur Cytokine Netw; 2002; 13(1):39-45. PubMed ID: 11956019
[TBL] [Abstract][Full Text] [Related]
17. Triterpenoids from Cimicifugae rhizoma, a novel class of inhibitors on bone resorption and ovariectomy-induced bone loss.
Li JX; Liu J; He CC; Yu ZY; Du Y; Kadota S; Seto H
Maturitas; 2007 Sep; 58(1):59-69. PubMed ID: 17658706
[TBL] [Abstract][Full Text] [Related]
18. Macrophage colony-stimulating factor restores bone resorption in op/op bone in vitro in conjunction with parathyroid hormone or 1,25-dihydroxyvitamin D3.
Morohashi T; Corboz VA; Fleisch H; Cecchini MG; Felix R
J Bone Miner Res; 1994 Mar; 9(3):401-7. PubMed ID: 8191935
[TBL] [Abstract][Full Text] [Related]
19. Short-term local injections of transforming growth factor-beta 1 decrease ovariectomy-stimulated osteoclastic resorption in vivo in rats.
Beaudreuil J; Mbalaviele G; Cohen-Solal M; Morieux C; De Vernejoul MC; Orcel P
J Bone Miner Res; 1995 Jun; 10(6):971-7. PubMed ID: 7572322
[TBL] [Abstract][Full Text] [Related]
20. Cellular and molecular effects of growth hormone and estrogen on human bone cells.
Kassem M
APMIS Suppl; 1997; 71():1-30. PubMed ID: 9357492
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
